Response to Comments: Urological Supplies (DL33803)

This response-to-comments document for Urological Supplies (A58231) states that final LCD decisions are based on general acceptance by the medical community and supporting evidence (published original research, systematic reviews/meta-analyses, evidence-based consensus statements, and clinical guidelines) in accordance with CMS Program Integrity Manual Chapter 13. The DME MACs reviewed seven public comments during the 45-day comment period and used established evidence standards to formulate the final policy and responses.